Remdesivir-Maker Gilead's Lobbying Hit New High In 1st Quarter : Shots - Health News : NPR

https://www.npr.org/sections/health-shots/2020/05/02/849149873/gilead-lobbying-rose-as-interest-in-covid-19-treatment-climbed?origin=NOTIFY

 

Gilead, maker of Remdesivir spent a record amount lobbying

"Early drafts of the [CARES] legislation included a provision stipulating that COVID-19 vaccines, drugs and tests be affordable if they were developed with taxpayer funds. But the final bill included additional language that undercut that requirement.

 

Betty G. Robinson